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1. Introduction
Hearing loss (HL) is the most frequent sensory 
impairment, affecting 1 in 1,000 neonates worldwide 
(http://hearing.screening.nhs.uk/nationalprog). Many 
environmental factors, such as drug exposure, bacterial 
or viral infections and trauma, can cause HL; however, a 
significant proportion of cases is due to genetic factors. 
It is estimated that 70% of HL includes non-syndromic 
forms (NSHL), where the hearing deficit is the only 
clinical phenotype (1). Autosomal recessive mode 
of inheritance (ARNSHL) is highly heterogeneous, 
for which over 100 mapped loci are known to be 
involved (http://hereditaryhearingloss.org). Despite 
this, mutations in one single locus, DFNB1 (13q11-
12) which contains the GJB2 (NM_004004.5) and 
GJB6 (NM_001110219.2) genes, account for 50% of 
the etiology in many European populations (2). Their 
identification of the first GJB2 mutations causing hearing 
loss was soon followed by screenings that revealed a 
high frequency of GJB2 mutations among subjects with 
NSHL (3). The gene is 5513 bp long and contains only 
two exons with exon 1 being untranslated. To date, 361 
mutations in the GJB2 gene have been identified with 
variable frequency among disparate world populations 
(http://www.hgmd.cf.ac.uk). c.35delG is the most 
common mutation in many populations such as Iran (4,5). 
Other mutations have a more specific origin. In Japanese, 
235delC is more prevalent (6) and c.167delT is common 
in Ashkenazi Jews (7). Genetic diagnosis of ARNSHL 
is complicated, in terms of cost-effectiveness, due to the 
extreme genetic heterogeneity of this condition (8-11). 
So the high rate of GJB2 related HL in most populations 
(12,13), coupled with the simple structure of the gene, 
which facilitated the design of different molecular tests, 
made screening for GJB2 mutations the first step of 
genetic testing of ARNSHL (14). Here, we report a novel 
frameshift variant in a consanguineous Iranian family 
affected by profound ARNSHL. Our finding would be a 
great supplement for the GJB2 pathogenic mutations and 
would make genetic counseling available for this family.
2. Methods
2.1. Participants and molecular genetic testing
Clinical examination was carried out on the four 
affected subjects; family CHM-1 from a village 
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located in southwest Iran. A comprehensive family 
history, including age of onset, exposure to ototoxic 
drugs during pregnancy and childhood infections, 
was obtained. Further clinical examinations such as 
temporal bone CT scan, thyroid ultrasound scan and 
thyroid hormone assays were also carried out to rule out 
the involvement of other body organs and syndromic 
HL forms (Figure 1). Air and bone conduction pure tone 
audiometry from 250 to 8000 Hz was obtained from all 
affected. All members of this family were sampled for 
further molecular studies. Blood samples were collected 
after written informed consent was obtained from all 
individuals or their legal guardians (if patients were 
under 18). Written parental consent to publish was also 
obtained. The study was approved by the review boards 
and ethics committees of the Shahrekord University of 
Medical Sciences.
 Genomic DNA of subjects was extracted from 
peripheral blood lymphocytes using the standard salting 
out procedure (15). Purity and concentration of DNA 
samples were determined with a 1.2% agarose gel and 
spectrophotometer (Nanolytik, Dusseldorf, Germany). 
GJB2 was screened for the coding region mutations 
(exon 2) using direct sequencing. The following primers 
were used for amplification of exon 2 of the GJB2 gene: 
F1 (5′-GCTTACCCAGACTCAGAGAAG-3′) and R1 
(5′-CTACAGGGGTTTCAAATGGTTGC-3′). The PCR 
reaction was performed as follows: 8 μL of Master 
Mix 2x (containing, MgCl2, Taq DNA polymerase, 
and d NTPs (Applied Biosystems), 0.45 μL of each of 
the primers (10 pM), 2 μL DNA (50 ng), adjusted to 
18 μL using ddH2O. The amplification was initiated 
by denaturation at 95ºC for 5 minutes, followed by 
30 cycles of 95ºC for 1 minute, 60ºC for 1 minute, 
and 72ºC for 1 minute, with a final extension cycle of 
72ºC for 5 minutes. The automated Genetic Analyzer 
ABI 3130 XL (Applied Biosystems3130, Foster City, 
California, USA) was applied to directionally sequence 
PCR products using The Big Dye® Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems3130, Foster 
City, California, USA).
2.2. Computational analyses
We used Bioinformatics predictive tools including 
Mutation Taster, Polyphen and SIFT (16) to assess 
possible effects of mutations on the protein structure. 
Databases including: Connexin deafness homepage 
(http://davinci.crg.es/deafness), the Single Nucleotide 
Polymorphism database (dbSNP) (http://www.ncbi.nlm.
nih.gov/project/SNP) and the 1000 Genomes Project 
(http://browser.1000genomes.org) were investigated for 
novel variants.
3. Results
3.1. Clinical Evaluation
In the four-generation consanguineous family CHM-1, 
four individuals (III-3, IV-2, IV-2, IV-3), were affected 
by pre-lingual bilateral profound sensorineural HL 
(Figure 2A). The deaf siblings had normal parents and 
helped to correctly define the mode of inheritance as 
autosomal recessive. In accordance with the subjects’ 
interviews indicating a pre-lingual onset of deafness, 
31
Figure 1. Temporal bone CT image of IV: 1. based on the criteria 
of diameter greater than 1.5 mm between the outer vestibular 
aqueduct and the vestibule of the total port foot or the midpoint 
of the isthmus is abnormal.
Figure 2. (A) Pedigree and segregation of the c.109_110insG variant in Iranian family CHM-1; −/−and +/+ respectively, show the 
homozygous (mutant) genotype and wild-type (WT) allele. (B) Right and left ear audiograms in the (IV: 2) patient.
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protein) (Figure 4). This practically means complete 
deletion of about 75% of the Cx26 protein. Figure 3 
shows location of the variant in the first TM domain of 
the Cx26 protein.
4. Discussion
Various genes causing autosomal recessive non-
syndromic hearing loss (ARNSHL) has been identified 
from Iran; but mutations related to the GJB2 gene have 
been reported more frequently (17-19). Here, a novel 
homozygous variant identified by Sanger sequencing 
is reported within an Iranian family. The prevalence 
of GJB2 mutations in Iran ranges from 4 to 38% 
in different ethnic groups (14). Such mutations are 
among the most frequent causes of HL in the world, 
and their prevalence exceeds over 50% in certain 
populations (20). GJB2, encodes the connexin26 
(Cx26) gap-junction channel protein that underlies both 
intercellular communication among supporting cells 
and homeostasis of the cochlear fluids, endolymph 
and perilymph. Connexin proteins that contain one 
cytoplasmic domain (CL), two extracellular domains 
(E 1-2), and four transmembrane (TM 1-4) domains 
are concentrated within the membrane as connexons 
or hemi channels. Newly-synthesized Cx26 monomers 
language acquisition was severely impaired in all 
affected individuals. More clinical examinations did not 
indicate any thyroid, skin, or ophthalmic abnormalities 
in affected members. Therefore, a syndromic form 
of HL was ruled out. The pedigree revealed several 
consanguineous marriages, suggesting ARNSHL in the 
offspring. Pure-tone audiometry in affected subjects 
showed flat audiograms characteristic of profound 
hearing impairment (Figure 2B).
3.2. GJB2 Mutation Screening
Sequencing of GJB2 showed a novel homozygous 
variant (c.109_110insG) in the three affected siblings 
and their deaf aunts (Figure 3A). This variant was not 
found in other normal hearing family members, and was 
unique to those affected. Additionally, no other mutation 
in GJB2 was identified in either of the subjects. 
c.109_110insG was not detected in 100 ethnicity-
matched controls. All in silico programs predicted the 
c.109_110insG variant to have damaging effects (Table 
1). Further analysis of c.109_110insG showed that 
the variant was not reported by 1000 genome project. 
This frameshift variant (p. Val37Gly*11) creates a stop 
codon at amino acids 47, resulting in a truncated protein 
with only 47 residues (versus 226 residues in the intact 
Table 1. Identified GJB2 variant and in silico analyses
Mutation
c.109_110insG
Amino acid 
change
Val37Gly fs*11
mutation 
type 
Insertion
Affected 
domain
TM1
classification
Trancated
SIFT
Damaging
CADD
23
Mutation Taster
Disease causing
Segregates in 
the family
Yes
ACMG
Pathogenic
Functional effect
Figure 3. (A) Sequencing results of the c.109_110insG variant. (B) Schematic structure, domains and location of new variant of the Cx-26 
protein in this study.
Figure 4. The putative schematic representation of connexin26 protein and mutants in family CHM-1. The new variant c.109_110insG 
induced a frameshift mutation, caused a stop codon at position of amino acid 47, resulting in truncated connexin26 protein.
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undergo conformational maturation and assembly into 
connexons when moving along the secretory pathway 
for delivery at the plasma membrane. Once there, Cx26 
connexons may remain as so-called hemi channels, 
allowing for transport of diverse small molecules (less 
than 1 kDa) between the cytosol and the extracellular 
space. Until now, more than 100 mutations in GJB2 
have been reported to cause ARNSHL. They involve a 
wide spectrum of missense, nonsense, frame shift and 
splice site mutations (http://davinci.crg.es/deafness). 
However, one truncated mutation (c.35delG) is most 
frequent in the majority of the Caucasian population, 
with the carrier frequency as high as 2-4% (21). 
Here, we identified a novel homozygous variant, p. 
Val37Gly*11 in the first TM domain of the Cx26 
protein, which is highly conserved in all species studied, 
and among different connexions (Figure 5). This 
frameshift variant was predicted to result in a truncated 
protein missing parts of the TM1-4, intervening loops 
and C-terminal (Figure 3B) which hampers Cx26 
folding and oligomerization, leading to retention at the 
endoplasmic reticulum (ER) and ultimately causing a 
total loss of function (22). Interestingly, ER retention 
of the truncated subunits may induce in some cases 
the unfolded protein response, which in turn may 
eventually lead to apoptosis of cells expressing those 
GJB2 mutant alleles (23). Unfortunately, there has been 
no in vitro functional assay to evaluate the mechanism 
by which GJB2 mutations cause HL. In this case, other 
available lines of evidence such as those derived from 
segregation studies should be incorporated to pinpoint 
true genetic causes. The ACMG guidelines advocated 
our finding (24). The frameshift variant is a null allele 
leading to a truncated protein (PVS1), the variant 
was seen in all affected family members and was not 
detected in normal subjects (PS4) and bioinformatics 
analyses support a deleterious effect on Cx26 protein 
(PP3). It is located in a validated domain (TM1), this 
variant reduces the length of the protein (PM4) and was 
not reported by the dbSNP database and 1000 genome 
project (PM2). Thus, the variant is categorized as being 
pathogenic. 
 This study should be a great supplement for the role 
of GJB2 mutations in the etiology of ARNSHL, in the 
Iranian population. Furthermore, our data support the 
view that the investigation of GJB2 mutations is still 
the primary step before moving on to next-generation 
sequencing (NGS) (25). The use of Sanger sequencing 
for detection of GJB2 mutations may be a faster 
and more economical diagnostic tool in individuals 
suffering with pre-lingual HL.
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